Denmark· DK-28104956711
Zyclara
A imiquimod product containing imiquimod, registered in Denmark by Viatris Healthcare Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Imiquimod is registered in 16 of 19 countries.
Countries holding a registration under ATC D06BB10 (imiquimod), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Imiquimod · ATC D06BB10
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Imiquimod
- Manufacturer
- Viatris Healthcare Limited
- Country
- Denmark (DK)
- ATC code
- D06BB10
- ATC class
- Imiquimod
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104956711
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
74 interactions on record for imiquimod.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Imiquimod · interactions on record
74 records
- 1 severe
- 3 moderate
- 70 info
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Porfimer sodiumL01XD01moderate
- MethoxsalenL01XD10moderate
- VerteporfinS01LA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under D06BB10
Imiquimod, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e10fcb95-6680-4430-bf6c-c314e03e48ce GET /v1/drugs/e10fcb95-6680-4430-bf6c-c314e03e48ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "creme",
"source": "dkma",
"strength": "3,75% w/w",
"auth_role": "MOD",
"dk_drugid": "28104956711",
"substance": "Imiquimod",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "41144"
}See everything about imiquimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.